There is considerable current interest amongst scientists and clinicians in the combined use of nitroimidazoles such as misonidazole (MISO) and cytotoxic chemotherapy. This meeting was arranged to review progress in the field since the first U.K. Workshop held at the CRC. Gray Laboratory and the International meeting at Key Biscayne, Florida in June and September, 1981 respectively (Fowler, 1982; Sutherland, 1982) . It was attended by 30 invited participants from the U.K., nearly all of whom are active workers in the field, and data contributions were also made by Drs. J.M. Brown and D. Hirst (Stanford) 
